{"id":"NCT01494987","sponsor":"Gilead Sciences","briefTitle":"Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus","officialTitle":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01","primaryCompletion":"2013-08","completion":"2013-08","firstPosted":"2011-12-19","resultsPosted":"2014-09-01","lastUpdate":"2014-11-18"},"enrollment":431,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Ranolazine","otherNames":["RanexaÂ®"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Glimepiride","otherNames":[]},{"type":"BEHAVIORAL","name":"Diet","otherNames":[]},{"type":"BEHAVIORAL","name":"Exercise","otherNames":[]}],"arms":[{"label":"Ranolazine+glimepiride","type":"EXPERIMENTAL"},{"label":"Placebo+glimepiride","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized, double-blind, placebo-controlled, parallel-group, multi-center study to determine the effect of ranolazine when added to glimepiride on glycemic control in adults with type 2 diabetes mellitus (T2DM) who are inadequately controlled despite current treatment with stable sulfonylurea or metformin therapy in addition to diet and exercise.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 24","timeFrame":"Baseline; Week 24","effectByArm":[{"arm":"Placebo+Glimepiride","deltaMin":8.08,"sd":1.07},{"arm":"Ranolazine+Glimepiride","deltaMin":7.58,"sd":1.089}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":32},"locations":{"siteCount":140,"countries":["United States","Czechia","Hungary","Malaysia","Poland","Romania","Russia","Serbia","Slovakia","South Africa","Thailand","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":216},"commonTop":["Hyperglycemia","Hypoglycaemia","Nausea"]}}